Scadenza: 7 September 2022
Topic:
Investments are needed to establish, scale-up or improve primary cancer prevention programmes. The barriers that prevent their uptake and effective implementation should be identified and addressed. Also, primary cancer prevention programmes should be tailored to the particular needs of the target populations, taking into account socio-economic, cultural and geographical conditions. Digital tools and datasets may be considered where needed.
Proposals should address all of the following:
- Focus on implementation and upscaling of evidence-based primary cancer prevention interventions, at local, regional or national level, addressing known risk or protective factors and determinants[4]. Proposals should clearly justify and describe the existing evidence supporting the chosen intervention, including evidence of cost-effectiveness and affordability, across health or other sectors.
- As effective prevention includes behavioural change, due consideration should be given to the factors that facilitate or impede behavioural change.
- Identify and address the bottlenecks and barriers that might influence uptake and implementation of cancer prevention programmes in accessible, affordable and equitable ways, and their impact in a defined public health context.
- Provide evidence and recommendations to inform policy and decision-makers and propose a pathway to integrate the intervention into local, regional or national health systems, policies and practices.
- Applicants are required to co-create with relevant stakeholders, including representatives of citizens, people at risk of cancer, patients, survivors, health practitioners, payers, and policymakers in the design and conduct of research and evaluation of its outcomes. Such partners will be integral to the success and sustainability of the programme and it is essential that they are engaged early in the definition of problems and barriers.
- Proposals should align with commitments or planned commitments at a regional or country level to implement evidence-based interventions. Researchers should collaborate closely with responsible authorities. The latter should provide the interventions and the financial means.
- Approaches, methodologies and frameworks used should be specific to implementation science, and based on appropriate outcomes, such as feasibility, acceptability, sustainability, uptake and cost effectiveness.
- The design of the proposed interventions should take the gender dimension and ethics into account, and contribute to reducing health inequalities.
- The organisational and resource requirements (data, digital tools, personnel and financing) necessary for the implementation of the intervention must be described, tracked and evaluated in detail. The research and system-wide scientific monitoring should allow future users (researchers, healthcare providers, policy makers, and the public) to review the step-by-step, partial outcomes of the intervention, thus facilitating a wider adoption of these practices. The appropriate contextual, financial and political-economic analyses should be provided.
Programma:
HORIZON-RIA HORIZON Research and Innovation Actions
Ente finanziatore:
EU
Budget complessivo:
The total indicative budget for the topic is EUR 50.00 million
Who can participate:
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
– the Member States of the European Union, including their outermost regions;
– the Overseas Countries and Territories (OCTs) linked to the Member States;
– eligible non-EU countries:
– countries associated to Horizon Europe;
– low- and middle-income countries
Partnership: Mandatory
Status:
Closed
Quota finanziabile:
100%
Topic:
Investments are needed to establish, scale-up or improve primary cancer prevention programmes. The barriers that prevent their uptake and effective implementation should be identified and addressed. Also, primary cancer prevention programmes should be tailored to the particular needs of the target populations, taking into account socio-economic, cultural and geographical conditions. Digital tools and datasets may be considered where needed.
Proposals should address all of the following:
- Focus on implementation and upscaling of evidence-based primary cancer prevention interventions, at local, regional or national level, addressing known risk or protective factors and determinants[4]. Proposals should clearly justify and describe the existing evidence supporting the chosen intervention, including evidence of cost-effectiveness and affordability, across health or other sectors.
- As effective prevention includes behavioural change, due consideration should be given to the factors that facilitate or impede behavioural change.
- Identify and address the bottlenecks and barriers that might influence uptake and implementation of cancer prevention programmes in accessible, affordable and equitable ways, and their impact in a defined public health context.
- Provide evidence and recommendations to inform policy and decision-makers and propose a pathway to integrate the intervention into local, regional or national health systems, policies and practices.
- Applicants are required to co-create with relevant stakeholders, including representatives of citizens, people at risk of cancer, patients, survivors, health practitioners, payers, and policymakers in the design and conduct of research and evaluation of its outcomes. Such partners will be integral to the success and sustainability of the programme and it is essential that they are engaged early in the definition of problems and barriers.
- Proposals should align with commitments or planned commitments at a regional or country level to implement evidence-based interventions. Researchers should collaborate closely with responsible authorities. The latter should provide the interventions and the financial means.
- Approaches, methodologies and frameworks used should be specific to implementation science, and based on appropriate outcomes, such as feasibility, acceptability, sustainability, uptake and cost effectiveness.
- The design of the proposed interventions should take the gender dimension and ethics into account, and contribute to reducing health inequalities.
- The organisational and resource requirements (data, digital tools, personnel and financing) necessary for the implementation of the intervention must be described, tracked and evaluated in detail. The research and system-wide scientific monitoring should allow future users (researchers, healthcare providers, policy makers, and the public) to review the step-by-step, partial outcomes of the intervention, thus facilitating a wider adoption of these practices. The appropriate contextual, financial and political-economic analyses should be provided.
Who can participate:
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
– the Member States of the European Union, including their outermost regions;
– the Overseas Countries and Territories (OCTs) linked to the Member States;
– eligible non-EU countries:
– countries associated to Horizon Europe;
– low- and middle-income countries
Programme:
HORIZON-RIA HORIZON Research and Innovation Actions
Consortium: Required
Status: Open
Total budget:
The total indicative budget for the topic is EUR 50.00 million
Funding rate:
100%
Notes:
Clinical trials and translational research are not within the scope of this topic.
The Commission estimates that an EU contribution of between EUR 3.00
and 8.00 million would allow these outcomes to be addressed
appropriately
